Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Recognizing thrombotic thrombocytopenic purpura (TTP) in a woman with lupus and starting combined treatment — Cablivi (caplacizumab) on top of plasma exchange, corticosteroids,…
The cases of adult siblings in Israel, both diagnosed with infantile-onset acquired thrombotic thrombocytopenic purpura (TTP) as children, led to the discovery of a…